Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sequence Deeper and Discover More!

Published: Monday, March 11, 2013
Last Updated: Monday, March 11, 2013
Bookmark and Share
Epicentre’s new Globin-Zero™ Gold Kit distributed exclusively in the UK by Cambio.

Cambio now supplies UK life scientists with the new Globin-Zero™ Gold Kit from Epicentre. This innovative product is used to clean up excess globin mRNA and rRNA in total blood RNA samples, allowing improved identification and sequencing of the target RNA components.

Globin-Zero™ Gold Kits efficiently remove abundant globin RNAs from both intact and degraded human, mouse and rat total blood RNA samples.

In these samples, as much as 70% of the mRNA can be globin mRNA, and this would account for a large majority of sequencing reads in RNA-Seq experiments.

By removing excess RNA, the Globin-Zero™ Gold Kit enables deeper sequencing into blood RNA samples and improved identification of less abundant RNA types, including viral RNA.

Complete in just 90 minutes, the rapid, single-pass process saves time and reduces sample waste compared to common multi-step procedures, which require the use of various kits to complete the same task.

Using the Globin-Zero™ Gold Kit, researchers can collect even more information from their investigations by retaining non-globin mRNA and large non-ribosomal, non-coding RNA for whole transcriptome RNA-Sequencing.

The magnetic bead format means that the technique can be used with both manual and automated processing, further reducing the hands-on time required.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Cell Cargo Ships in Near Future?
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Unravelling the Roots of Insect’s Waterproof Coating
Researchers have identified the genes that control cuticular lipid production in Drosophila, by performing an RNAi screen and using Direct Analysis in Real Time and GC-MS.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!